JagsonpalPharmaceuticals JAGSNPHARM full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

• Tips
• NEWS
• Tomorrow
• Forecast
• Targets
• ExpertsView
• Analysis
• Munafa AI prediction

• IntraDay predictions, targets, What to do JAGSNPHARM
• Forcast & Targets JAGSNPHARM
• JAGSNPHARM Experts view
• Tomorrow's Movement JAGSNPHARM
• Technical Analysis Reports
• All in One Charts
• All indicators in One Charts
• JAGSNPHARM History
• Money flow charts
• Weekly charts
• Monthly charts
• Moving averages charts
• MACD charts
• Force Index charts
• Stochastics charts
• PVM charts
• RSI and MRSI charts
• Renko charts
• Point and Figure charts

Daily Price and Volume

Weekly Price and Volume

Monthly Price and Volume

Yearly Price and Volume

Indicator Analysis of JagsonpalPharmaceuticals

Tomorrow's movement Prediction of Jagsonpal Pharmaceuticals JAGSNPHARM appears to be in downtrend.

But this trend seems to be weakening.

Price is below an important level of 186.73 on charts, and if price remains below this level, then stock might show a fall in short term.

Tomorrow's movement Prediction of Jagsonpal Pharmaceuticals JAGSNPHARM appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.

Tomorrow's movement Prediction of Jagsonpal Pharmaceuticals JAGSNPHARM appears strongly Bearish. This stock started falling as soon as it opened and never recovered during the session. Generally this happens when there is a negative sentiment following the stock, making it unattractive. There's a good chance that this downfall will continue tomorrow as well. However, if it manages to close higher than where it opened today, then there might be a chance of reversal.

Munafa value: 25 as on Wed 14 January 2026

This Munafa value indicates that the stock is moving downwards and might continue to move down.

SMA20 is at 193 and price is deviating by 8 points

Upper Bollinger band is at 207 and lower is at 178, while middle bands are at 185 and 200

Price is coming down

Price is below 20day SMA

Price is in lower range of bands

Price action analysis of JagsonpalPharmaceuticals (JAGSNPHARM) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for JagsonpalPharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for JagsonpalPharmaceuticals in short term and the sell signal is strong.

JagsonpalPharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for JagsonpalPharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of JagsonpalPharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 185.78 and JagsonpalPharmaceuticals JAGSNPHARM stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the JagsonpalPharmaceuticals JAGSNPHARM stock. Volume based technical analysis of JagsonpalPharmaceuticals JAGSNPHARM stock is negative.

JagsonpalPharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Jagsonpal Pharmaceuticals JAGSNPHARM

DMA (daily moving average) of Jagsonpal Pharmaceuticals JAGSNPHARM

DMA period	DMA value
5 day DMA	181.91
12 day DMA	187.51
20 day DMA	192.11
35 day DMA	198.48
50 day DMA	201.77
100 day DMA	215.83
150 day DMA	225.62
200 day DMA	225.04

EMA (exponential moving average) of Jagsonpal Pharmaceuticals JAGSNPHARM

EMA period	EMA current	EMA prev	EMA prev2
5 day EMA	181.96	183.76	184.62
12 day EMA	186.73	188.25	189.38
20 day EMA	190.75	192.05	193.1
35 day EMA	196.37	197.43	198.34
50 day EMA	201.5	202.44	203.27

SMA (simple moving average) of Jagsonpal Pharmaceuticals JAGSNPHARM

SMA period	SMA current	SMA prev	SMA prev2
5 day SMA	181.91	184.55	185.47
12 day SMA	187.51	188.82	190.07
20 day SMA	192.11	193.1	193.99
35 day SMA	198.48	199	199.49
50 day SMA	201.77	202.73	203.54
100 day SMA	215.83	216.48	217.15
150 day SMA	225.62	225.99	226.32
200 day SMA	225.04	225.21	225.41

Fundamentals, profit and EPS of Jagsonpal Pharmaceuticals JAGSNPHARM

EPS is 9.32 and PE is: 19.14

Last quarter profit: (September 2025 quarter) 12.57 crores (9.69%)

Debt: 8.84 in crores

Market capitalization: 1337.35

EPS is 9.16 and PE is: 19.47

Last quarter profit: (June 2025 quarter) 10.80 crores (38.64%)

Debt: 9.24 in crores

Market capitalization: 1556.97

Videos related to: JagsonpalPharmaceuticals JAGSNPHARM full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI